IBRITUMOMAB TIUXETAN — all Canadian products
1 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is IBRITUMOMAB TIUXETAN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02328674 | ZEVALIN | AURO PHARMA INC | Kit; Solution | Intravenous | IBRITUMOMAB TIUXETAN 3.2 MG | Approved |
Browse other molecules: